Clinical trial

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

NCT02330406

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-04-01

PhasePHASE4

Study timeline

Study start (actual)2015-04-01Date precision: month

Registry last updated2019-08-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Dipeptidyl-Peptidase 4 Inhibitorsunresolved

LDL Cholesterolunresolved

Glycosylated Hemoglobinunresolved

Diabetes Mellitusunresolved

Coronary Diseaseunresolved

Interventions

AnagliptinDRUG

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sponsors & collaborators

Institute for Clinical Effectiveness, Japanlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02330406 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.